000			01517 a2200445 4500
005			20250517131026.0
264		0	_c20180104
008			201801s 0 0 eng d
022			_a2352-3026
024	7		_a10.1016/S2352-3026(16)30153-3 _2doi
040			_aNLM _beng _cNLM
245	0	0	_aCan we not bleed? _h[electronic resource]
260			_bThe Lancet. Haematology _cNov 2016
300			_ae497 p. _bdigital
500			_aPublication Type: Editorial
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAntibodies _xadverse effects
650	0	4	_aBlood Coagulation Disorders, Inherited _xeconomics
650	0	4	_aBlood Coagulation Factors _xantagonists & inhibitors
650	0	4	_aBlood Transfusion
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aCost of Illness
650	0	4	_aDrug Contamination _xeconomics
650	0	4	_aFactor IX _xtherapeutic use
650	0	4	_aFactor VIII _xtherapeutic use
650	0	4	_aHealth Expenditures
650	0	4	_aHumans
650	0	4	_aImmunoglobulin Fc Fragments _xtherapeutic use
650	0	4	_aInfusions, Intravenous _xpsychology
650	0	4	_aMobile Applications
650	0	4	_aQuality of Life
650	0	4	_aRecombinant Fusion Proteins _xtherapeutic use
650	0	4	_aRecombinant Proteins _xtherapeutic use
650	0	4	_aUnited Kingdom
650	0	4	_aVideo Games
773	0		_tThe Lancet. Haematology _gvol. 3 _gno. 11 _gp. e497
856	4	0	_uhttps://doi.org/10.1016/S2352-3026(16)30153-3 _zAvailable from publisher's website
999			_c26696375 _d26696375